PROJECT SUMMARY
This goal of this proposal is to revise the District of Columbia Center for AIDS Research (DC CFAR)
Administrative Core to include the CFAR Pathway Programs Coordinating Center (CPPCC). The CPPCC will
include three Cores:
The Administrative Core will be led by the DC CFAR Director Dr. Alan Greenberg and Administrative Director
Ms. Brandi Robinson. The CPPCC will be responsible for fiscal oversight of CPPCC resources, maintenance of
the CPPCC website, developing and disseminating the quarterly CPPCC e-newsletter, and coordinating cross-
CFAR scientific publication efforts. The Administrative Core will schedule quarterly meetings with the CFAR
pathway program leads and with the NIH CFAR Program Office.
The Program Core will be led by Dr. Anthony Wutoh, Howard University Provost and DC CFAR Developmental
Core Co-Director, and Dr. Lisa Bowleg, DC CFAR Social and Behavioral Science Core Co-Director. The
Program Core will convene quarterly meetings of the CFAR pathway program leads which will be the principal
forum for exchanging programmatic ideas, identifying best practices and common challenges, and providing
high-level feedback to the NIH. The Program Core will also develop cross-CFAR activities such as facilitating
access to didactic sessions across CFAR sites, cross-CFAR exchange of information about mentored research
experiences, and national meetings of CDEIPI scholars and mentors.
The Evaluation Core will be led by the DC CFAR Co-Director Dr. ManyaMagnus and Senior Research
Program Manager Ms. Lorena Segarra. The Evaluation Core will convene quarterly meetings of the CFAR
pathway program evaluation leads to coordinate the monitoring and evaluation components of CFAR pathway
programs; chronicle the development of the program approaches; develop, harmonize, and assess short- and
long-term process and outcome measures; and conduct qualitative and quantitative research about the overall
delivery and impacts of the program. The three primary activities will be building and implementing a
consensus-based evaluation strategy with CFAR pathway programs; collecting, managing and analyzing
individual- and aggregate-level characteristics to inform our understanding of the challenges and successes
encountered by newly and previously funded CFAR pathway programs; and leading innovative approaches to
describe the impact of the CFAR pathway programs.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Acquired Immunodeficiency SyndromeAddressBehavioral SciencesCharacteristicsCollaborationsCommunicationConsensusDevelopmentDistrict of ColumbiaEvaluationFeedbackFundingGoalsGovernmentIndividualInstitutionLeadershipMaintenanceMentorsMonitorNewsletterOutcome MeasurePathway interactionsProcess MeasureProgram DevelopmentProgram EvaluationPublicationsResearchResearch PersonnelResourcesScheduleScienceSiteUnited States National Institutes of HealthUniversitiescommunity partnersexperienceinnovationmeetingsmultidisciplinaryprogramssocial science researchsuccessweb siteworking group
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
043990498
UEI
ECR5E2LU5BL6
Project Start Date
01-June-2015
Project End Date
31-May-2025
Budget Start Date
01-September-2024
Budget End Date
31-August-2025
Project Funding Information for 2024
Total Funding
$503,417
Direct Costs
$324,188
Indirect Costs
$179,229
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$503,417
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3P30AI117970-10S3 9758
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3P30AI117970-10S3 9758
Patents
No Patents information available for 3P30AI117970-10S3 9758
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3P30AI117970-10S3 9758
Clinical Studies
No Clinical Studies information available for 3P30AI117970-10S3 9758
News and More
Related News Releases
No news release information available for 3P30AI117970-10S3 9758
History
No Historical information available for 3P30AI117970-10S3 9758
Similar Projects
No Similar Projects information available for 3P30AI117970-10S3 9758